## Abstract Negative symptoms are considered the most debilitating and refractory aspect of schizophrenia, being associated with poor social, occupational and global outcomes. Conventional antipsychotics have limited efficacy against these symptoms and poor tolerability profiles. Atypical antipsych
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia
✍ Scribed by Michael Riedel; Norbert Müller; Ilja Spellmann; Rolf R. Engel; Richard Musil; Rosamaria Valdevit; Sandra Dehning; Anette Douhet; Anja Cerovecki; Martin Strassnig; Hans-Jürgen Möller
- Publisher
- Springer-Verlag
- Year
- 2007
- Tongue
- English
- Weight
- 316 KB
- Volume
- 257
- Category
- Article
- ISSN
- 1433-8491
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A __post hoc__ analysis of the SPECTRUM trial was carried out to evaluate whether the improvements in efficacy and tolerability gained on switching to quetiapine occurred consistently for patients previously treated with either: haloperidol (__n__ = 43); olanzapine (__n__ = 66); or risp
## Abstract ## Objective To examine the effects of risperidone and olanzapine on cognitive functioning in elderly patients with schizophrenia or schizoaffective disorder. ## Method One hundred seventy‐six elderly inpatients and outpatients with schizophrenia or schizoaffective disorder were enro
Background Following an earlier study in which elderly patients with schizophrenia had their typical antipsychotic medication changed to olanzapine or risperidone, the 61 patients were followed for up to a further six months to see if either treatment was superior in terms of efficacy or side effect